Cite
MLA Citation
Hendrik‐Tobias Arkenau et al.. “Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF).” Oncologist, vol. 23, 2018, pp. 1407–e136. http://access.bl.uk/ark:/81055/vdc_100076295739.0x000024